首页> 外文OA文献 >Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions

【2h】

Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions

机译：英夫利昔单抗加上静脉注射免疫球蛋白（IVIG）与IVIG作为冠状动脉病变患儿童的初始治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Pei-Ni Jone; Marsha S. Anderson; Matthew J. Mulvahill; Heather Heizer; Mary P. Glodé; Samuel R. Dominguez;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective? [J] . Jone Pei-Ni, Anderson Marsha S., Mulvahill Matthew J., The Pediatric infectious disease journal . 2018,第10期

机译：英夫利昔单抗加上静脉内免疫球蛋白（IVIG）与IVIG单独作为汗崎病患儿患有冠状动脉病变的初始治疗：双重治疗更有效吗？
2. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study [J] . Zhenquan Wang, Fengfeng Weng, Chen Li, BMC Pediatrics . 2018,第1期

机译：静脉内免疫球蛋白治疗后中性粒细胞减少症与Kawasaki疾病儿童的冠状动脉病变有关：案例对照研究
3. EFFICACY OF PRIMARY TREATMENT WITH IMMUNOGLOBULIN PLUS CYCLOSPORINE FOR PREVENTION OF CORONARY ARTERY ABNORMALITIES IN KAWASAKI DISEASE PATIENTS PREDICTED TO BE AT INCREASED RISK OF IVIG NON-RESPONSE (KAICA STUDY): A CONTROLLED, PHASE 3, RANDOMISED, OPEN-LABEL, BLINDED-ENDPOINTS TRIAL [J] . Hamada Hiromichi, Suzuki Hiroyuki, Onouchi Yoshihiro, Rheumatology . 2019,第Suppla2期

机译：用免疫球蛋白加上川孢菌素预防川崎病患者冠状动脉异常的疗效预计患者的冠状动脉异常（KAICA研究）的风险增加（KAICA研究）：一个受控，第3阶段，随机，开放标签，盲终点试验
4. Coronary Artery Bypass Grafting for Coronary Stenosis Caused by Kawasaki Disease [C] . E. Tsuda World Congress on Heart Disease . 2007

机译：川崎病造成的冠状动脉狭窄冠状动脉旁路移植
5. Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease [D] . Miyakoshi, Chisato 2019

机译：川崎病的心率，对静脉免疫球蛋白的反应性和冠状动脉瘤
6. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children with Kawasaki Disease Presenting with Coronary Artery Lesions: Is Dual Therapy More Effective? [O] . Pei-Ni Jone, Marsha S. Anderson, Matthew J. Mulvahill, -1

机译：英夫利昔单抗加静脉免疫球蛋白（IVIG）与单独使用IVIG作为川崎病伴冠状动脉病变的儿童的初始治疗：双重疗法是否更有效？
7. Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease [O] . Ji Whan Han 2018

机译：预测抗静脉内免疫球蛋白的抗性抗肺崎病患者的因素：川崎病患者的IVIG抗性

Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions

著录项

相似文献

相关主题

期刊订阅